Peng Ding-Shan, Lo Chih-Hui, Tseng Yu-Lun, Kuo Shun Li, Chiang Chun-Pin, Chiang Meng-Ling
Department of Dentistry, Chang Gung Memorial Hospital at Taoyuan, Taoyuan, Taiwan.
School of Pharmacy, National Defense Medical Center, Taipei, Taiwan.
J Dent Sci. 2022 Oct;17(4):1802-1813. doi: 10.1016/j.jds.2022.08.005. Epub 2022 Aug 26.
BACKGROUND/PURPOSE: Previous studies have shown that some of the patients with oral mucosal dysesthesia but without objective oral mucosal manifestations (so-called oral dysesthesia patients in this study) may have good responses to oral nystatin treatment. This study evaluated the efficacy of oral nystatin treatment for oral dysesthesia patients and the necessity of culture test before oral nystatin treatment.
The 147 oral dysesthesia patients were divided into 3 groups: culture (+) group (n = 29), culture (-) group (n = 34), and without culture test group (n = 84), and treated with oral nystatin. The pain improvement was evaluated by the reduction of numeric pain rating scale (NRS) and global perceived effects (GPE). We defined the GPE score ≥4 points as a great improvement.
We found that 44.8% of 29 patients in the culture (+) group, 47.1% of 34 patients in the culture (-) group, and 47.6% of 84 patients in the without culture test group showed a significant reduction in the NRS score and achieved a great improvement after oral nystatin treatment for 1-4 weeks. Moreover, 72.4% of our 29 patients with culture test achieved a great improvement within one week, and all the 29 patients achieved a great improvement within 4 weeks of oral nystatin treatment.
A portion of our oral dysesthesia patients are infected by and it is beneficial to our patients to use oral nystatin treatment before the culture test.
背景/目的:既往研究表明,部分有口腔黏膜感觉异常但无客观口腔黏膜表现的患者(本研究中所谓的口腔感觉异常患者)可能对口服制霉菌素治疗反应良好。本研究评估了口服制霉菌素治疗口腔感觉异常患者的疗效以及口服制霉菌素治疗前进行培养检测的必要性。
将147例口腔感觉异常患者分为3组:培养阳性组(n = 29)、培养阴性组(n = 34)和未进行培养检测组(n = 84),并给予口服制霉菌素治疗。通过数字疼痛评分量表(NRS)的降低和总体感觉效果(GPE)来评估疼痛改善情况。我们将GPE评分≥4分定义为显著改善。
我们发现,培养阳性组的29例患者中有44.8%、培养阴性组的34例患者中有47.1%以及未进行培养检测组的84例患者中有47.6%在口服制霉菌素治疗1 - 4周后NRS评分显著降低并实现了显著改善。此外,我们29例进行培养检测的患者中有72.4%在1周内实现了显著改善,所有29例患者在口服制霉菌素治疗4周内均实现了显著改善。
我们的部分口腔感觉异常患者受到[某种病原体]感染,在进行[病原体]培养检测前使用口服制霉菌素治疗对患者有益。